Matthew Padley, from Hyde, Greater Manchester, was diagnosed with myeloma in 2023 after experiencing severe back pain which at first he dismissed as "twinges" in 2022. An X-ray later found his back ...
Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...
Long-term remission in multiple myeloma—a blood cancer once considered incurable—is finally becoming a reality. A single ...
Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...
Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...
As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...
As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...
Kelley L. Julian, PharmD, BCOP, discusses optimizing MM care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.
A man in London thought he had injured his back, only to find out he has an incurable form of blood cancer. Terry Harper, 62, ...
The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend ...
He recalled his co-stars lovingly visiting him, with Tracey Bregman (Lauren) dropping by with tea and crumpets, and podcast ...